Nevertheless, recognizing the importance of understanding the roles of FAGs and PHKG2 and their regulatory mechanisms in NSCLC radiation resistance holds rich potential for further investigation and development to enhance cancer treatment outcomes. Here, PHKG2 is linked to non-small cell lung carcinoma.